Bharat Biotech to launch Covaxin in Q2 2021

The company's vaccine candidate -Covaxin- has been developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV) using inactivated Sars-Cov-2, the virus that causes COVID-19.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/3oJSdXN
via IFTTT